|
Sign In to gain access to subscriptions and/or personal tools.
|
 |
Adverse Events in HIV-infected Persons Receiving Antiretroviral Drug Regimens in a Large Urban Slum in Nairobi, Kenya, 2003-2005
Andrea A. Kim, PhD, MPH*,
Lucy Wanjiku,
Doris K. Macharia,
Mary Wangai,
Anthony Isavwa,
Hussein Abdi,
Barbara J. Marston,
Festus Ilako,
Mette Kjaer,
Kenneth Chebet,
Kevin M. De Cock,
and
Paul J. Weidle
Global AIDS Program, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention
* To whom correspondence should be addressed. E-mail: aakim{at}cdc.gov.
 |
Abstract |
|---|
Objective: This article describes toxicities to antiretroviral therapy (ART) among HIV-infected patients receiving care at a clinic in a large urban slum in Nairobi, Kenya. Methods: Patients were treated with nonnucleoside reverse transcriptase inhibitor-based ART and followed at scheduled intervals. Frequencies and cumulative probabilities of toxicities were calculated. Results: Among 283 patients starting ART, any and severe clinical toxicity were recorded as 65% and 6%, respectively. Cumulative probabilities for remaining free of any and severe clinical toxicities at 6, 12, and 18 months, were 0.47, 0.26, and 0.17, respectively and 0.98, 0.95, and 0.89, respectively. The probability of remaining free from elevated and grade 3 or 4 serum aminotransferase (AST) at 6, 12, and 18 months were 0.62, 0.42, and 0.21, respectively, and 0.99 at 6, 12, and 18 months. Conclusions: ART toxicities were frequent, but severe toxicities were less common. In resource-limited settings, ART toxicity should not represent a barrier to care.
First published on July 19, 2007, doi:10.1177/1545109707304494
Journal of the International Association of Physicians in AIDS Care (JIAPAC) 2007;6:206.
A more recent version of this article appeared on September 1, 2007
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
